These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20394700)

  • 1. Prevalence, awareness, treatment, and control of high LDL cholesterol in New York City, 2004.
    Upadhyay UD; Waddell EN; Young S; Kerker BD; Berger M; Matte T; Angell SY
    Prev Chronic Dis; 2010 May; 7(3):A61. PubMed ID: 20394700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cholesterol concentration and prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in the Korea National Health and Nutrition Examination Surveys 2008-2010: Beyond the Tip of the Iceberg.
    Lee YH; Lee SG; Lee MH; Kim JH; Lee BW; Kang ES; Lee HC; Cha BS
    J Am Heart Assoc; 2014 Feb; 3(1):e000650. PubMed ID: 24572249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults.
    Hyre AD; Muntner P; Menke A; Raggi P; He J
    Ann Epidemiol; 2007 Jul; 17(7):548-55. PubMed ID: 17395483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic lifestyle changes and drug treatment for high blood cholesterol in China and application of the Adult Treatment Panel III guidelines.
    Muntner P; Gu D; Reynolds RF; Wu X; Chen J; Whelton PK; He J
    Am J Cardiol; 2005 Nov; 96(9):1260-5. PubMed ID: 16253594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol--United States, 1999-2002 and 2005-200.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(4):109-14. PubMed ID: 21293326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in Brazil: Baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
    Lotufo PA; Santos RD; Figueiredo RM; Pereira AC; Mill JG; Alvim SM; Fonseca MJ; Almeida MC; Molina MC; Chor D; Schmidt MI; Ribeiro AL; Duncan BB; Bensenor IM
    J Clin Lipidol; 2016; 10(3):568-76. PubMed ID: 27206944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 through 2009-2010.
    Muntner P; Levitan EB; Brown TM; Sharma P; Zhao H; Bittner V; Glasser S; Kilgore M; Yun H; Woolley JM; Farkouh ME; Rosenson RS
    Am J Cardiol; 2013 Sep; 112(5):664-70. PubMed ID: 23726177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; ; ;
    Circulation; 2004 Jul; 110(2):227-39. PubMed ID: 15249516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China.
    He J; Gu D; Reynolds K; Wu X; Muntner P; Zhao J; Chen J; Liu D; Mo J; Whelton PK;
    Circulation; 2004 Jul; 110(4):405-11. PubMed ID: 15238453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Cholesterol Treatment Eligibility and Medication Use Among Adults--United States, 2005-2012.
    Mercado C; DeSimone AK; Odom E; Gillespie C; Ayala C; Loustalot F
    MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(47):1305-11. PubMed ID: 26633047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of changing national cholesterol education program goals for the treatment and control of hypercholesterolemia.
    Persell SD; Lloyd-Jones DM; Baker DW
    J Gen Intern Med; 2006 Feb; 21(2):171-6. PubMed ID: 16390501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Cholesterol Awareness, Treatment, and Control Among Hispanic/Latinos: Results From the Hispanic Community Health Study/Study of Latinos.
    Rodriguez CJ; Cai J; Swett K; González HM; Talavera GA; Wruck LM; Wassertheil-Smoller S; Lloyd-Jones D; Kaplan R; Daviglus ML
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26109505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of treatment with fluvastatin extended-release 80-mg tablets and immediate-release 40-mg capsules in patients with primary hypercholesterolemia.
    Isaacsohn JL; LaSalle J; Chao G; Gonasun L
    Clin Ther; 2003 Mar; 25(3):904-18. PubMed ID: 12852707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol Control Among Uninsured Adults Did Not Improve From 2001-2004 to 2009-2012 as Disparities With Both Publicly and Privately Insured Adults Doubled.
    Egan BM; Li J; Sarasua SM; Davis RA; Fiscella KA; Tobin JN; Jones DW; Sinopoli A
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002.
    Cullen MW; Stein JH; Gangnon R; McBride PE; Keevil JG
    Am Heart J; 2008 Aug; 156(2):284-91. PubMed ID: 18657658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of evidence-based "clinical judgment" on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data. National Health and Nutrition Examination Survey.
    Jacobson TA; Griffiths GG; Varas C; Gause D; Sung JC; Ballantyne CM
    Arch Intern Med; 2000 May; 160(9):1361-9. PubMed ID: 10809042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006.
    Kuklina EV; Yoon PW; Keenan NL
    JAMA; 2009 Nov; 302(19):2104-10. PubMed ID: 19920234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.